• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Number of foreign inspections completed by ORA in the month

Cumulative FY 2014 Target: 2,920

Dictionary: ORA investigators conduct on-site inspections of regulated foreign establishments and initiate enforcement actions to address violations of U.S. public health laws and regulations, and to proactively ensure the safety and efficacy of products manufactured abroad and sold in the USA.

Information is current as of November 19, 2014.

Fiscal Year - 2014

Skip graphic and jump to text data

Cumulative FY 2014 Target: 2,920

TimeTargetNumber of Inspections
Oct 2013N/A81
Nov 2013N/A172
Dec 2014N/A71
Jan 2014N/A133
Feb 2014N/A234
Mar 2014N/A77
Apr 2014N/A290
May 2014N/A322
Jun 2014N/A108
Jul 2014N/A320
Aug 2014N/A243
Sep 2014N/A284

FY 2014 Total: 2,335

Number of foreign inspections completed by ORA staff based abroad in the month

Dictionary: Information is current as of November 19, 2014.

Fiscal Year - 2014

Skip graphic and jump to text data

TimeTargetNumber of Inspections
Oct 2013N/A13
Nov 2013N/A26
Dec 2014N/A18
Jan 2014N/A12
Feb 2014N/A18
Mar 2014N/A22
Apr 2014N/A26
May 2014N/A21
Jun 2014N/A37
Jul 2014N/A17
Aug 2014N/A24
Sep 2014N/A25

FY 2014 Total: 259

Number of foreign inspections completed by ORA staff based in the USA in the month

Dictionary: Information is current as of November 19, 2014.

Fiscal Year - 2014

Skip graphic and jump to text data

TimeTargetNumber of Inspections
Oct 2013N/A68
Nov 2013N/A146
Dec 2014N/A53
Jan 2014N/A121
Feb 2014N/A216
Mar 2014N/A55
Apr 2014N/A264
May 2014N/A301
Jun 2014N/A71
Jul 2014N/A303
Aug 2014N/A219
Sep 2014N/A259

FY 2014 Total: 2,076

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.